(Q84082493)
Statements
Rimonabant improves cholesterol, insulin resistance and markers of non-alcoholic fatty liver in morbidly obese patients: a retrospective cohort study (English)
A S Wierzbicki
S Pendleton
Z McMahon
A Dar
J Oben
M A Crook